Acceleron Pharma To Host Educational Webcast Series With Clinical Thought Leaders

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced that it plans to host and webcast a series of online seminars with thought-leading experts in diseases for which sotatercept and luspatercept (ACE-536) are being developed. Acceleron and its collaboration partner, Celgene, are conducting phase 2 clinical trials of sotatercept and luspatercept in patients with lower-risk MDS, beta-thalassemia and end-stage renal disease with mineral and bone disorder.

Help employers find you! Check out all the jobs and post your resume.

Back to news